Top Five Global Medical Device Companies: Performance, Strategies, and Competitive Analysis, June 2012
According to this report, the global medical device industry has experienced high growth during the last five years and is expected to continue its growth momentum, reaching approximately $302 billion in 2017 with a CAGR of 6.1% over the next five years.
The global medical device industry has experienced high growth during the last five years and is expected to continue its growth momentum, reaching approximately $302 billion in 2017 with a CAGR of 6.1% over the next five years.
Lucintel, a leading global management consulting and market research firm, has conducted a competitive analysis of the global medical devices industry and presents its findings in -Top Five Global Medical Device Companies: Performance, Strategies, and Competitive Analysis.
The report provides detailed insight into the performance of the top five medical devices companies across the world. The analysis highlights the companies that are performing the best among the peer group, and in which areas, and therefore clarifies leading performance standards and the strengths and weaknesses of companies covered.
The medical device industry is highly fragmented and consists of surgical and infection control devices, general medical devices, cardiovascular, home healthcare, and other devices. North America dominates this industry. In this study, Lucintel thoroughly profile following five companies with detailed competitive assessments:
This study is intended to provide industry leaders with a concise overview of the world’s top five global medical equipment companies. This discussion is limited to a comparative analysis of the subject companies, their geographic footprints, financial metrics, market performance, marketing and corporate strategies, and SWOT analysis. It excludes the equipment such as orthopedic, in-vitro diagnostic, technical aids, and such other equipment.
This report will save hundreds of hours of your own personal research time and will significantly benefit you in expanding your business opportunities in global medical device companies. In today’s chaotic economy, you need every advantage that you can find to keep ahead in your business.
In Lucintel's newest competitive research study on the world's global medical device companies, we thoroughly profile following five companies with detailed competitive assessments:
The global medical device industry has experienced high growth during the last five years and is expected to continue its growth momentum, reaching approximately $302 billion in 2017 with a CAGR of 6.1% over the next five years.
Lucintel, a leading global management consulting and market research firm, has conducted a competitive analysis of the global medical devices industry and presents its findings in -Top Five Global Medical Device Companies: Performance, Strategies, and Competitive Analysis.
The report provides detailed insight into the performance of the top five medical devices companies across the world. The analysis highlights the companies that are performing the best among the peer group, and in which areas, and therefore clarifies leading performance standards and the strengths and weaknesses of companies covered.
The medical device industry is highly fragmented and consists of surgical and infection control devices, general medical devices, cardiovascular, home healthcare, and other devices. North America dominates this industry. In this study, Lucintel thoroughly profile following five companies with detailed competitive assessments:
- Abbott Laboratories
- Boston Scientific
- Covidien Plc.
- Johnson & Johnson
- Medtronic, Inc.
This study is intended to provide industry leaders with a concise overview of the world’s top five global medical equipment companies. This discussion is limited to a comparative analysis of the subject companies, their geographic footprints, financial metrics, market performance, marketing and corporate strategies, and SWOT analysis. It excludes the equipment such as orthopedic, in-vitro diagnostic, technical aids, and such other equipment.
This report will save hundreds of hours of your own personal research time and will significantly benefit you in expanding your business opportunities in global medical device companies. In today’s chaotic economy, you need every advantage that you can find to keep ahead in your business.
In Lucintel's newest competitive research study on the world's global medical device companies, we thoroughly profile following five companies with detailed competitive assessments:
- Abbott Laboratories
- Boston Scientific
- Covidien Plc
- Johnson & Johnson
- Medtronic, Inc.
- Company overview
- Benchmarking (financial & market)
- SWOT analysis
- Product positioning
- Marketing strategy and tactics
- Corporate strategy
- Regional analysis: global medical device companies services companies breakdown by key regions (e.g., North America, Europe, APAC and ROW)
- Market trends, drivers and forecasts
- Competitive benchmarking of each players against their financial & market strength
- Global and regional market share estimates for the top players
- Product line overview and positioning of top players
- SWOT analysis of the leaders
- Marketing strategy and tactics
- Corporate strategy
- More than 128 valuable figures/charts and 45 tables are provided in this report
1. EXECUTIVE SUMMARY
2. MARKET DEFINITION AND SCOPE
3. MARKET OPPORTUNITY
Supply Chain Porter’s Five Forces Analysis
4. COMPETITIVE BENCHMARKING (FINANCIAL AND MARKET)
Company Profile on Following Parameters
Company Overview
Benchmarking (Financial & Market)
SWOT Analysis
Product Positioning
Marketing Strategy and Tactics
Corporate Strategy
5. COMPANY PROFILE ON JOHNSON & JOHNSON
6. COMPANY PROFILE ON MEDTRONIC, INC.
7. COMPANY PROFILE ON COVIDIEN PLC
8. COMPANY PROFILE ON BOSTON SCIENTIFIC CORPORATION
9. COMPANY PROFILE ON ABBOTT LABORATORIES
2. MARKET DEFINITION AND SCOPE
3. MARKET OPPORTUNITY
Supply Chain Porter’s Five Forces Analysis
4. COMPETITIVE BENCHMARKING (FINANCIAL AND MARKET)
Company Profile on Following Parameters
Company Overview
Benchmarking (Financial & Market)
SWOT Analysis
Product Positioning
Marketing Strategy and Tactics
Corporate Strategy
5. COMPANY PROFILE ON JOHNSON & JOHNSON
6. COMPANY PROFILE ON MEDTRONIC, INC.
7. COMPANY PROFILE ON COVIDIEN PLC
8. COMPANY PROFILE ON BOSTON SCIENTIFIC CORPORATION
9. COMPANY PROFILE ON ABBOTT LABORATORIES
LIST OF FIGURES
CHAPTER 3. MARKET OPPORTUNITY
Figure 3.1: Supply chain for medical device industry
Figure 3.2: Global medical device industry trend (2006-2011)
Figure 3.3: Global medical device industry regional trend (2006-2011) US $B
Figure 3.4: Global medical device industry regional trend (2006-2011) (%)
Figure 3.5: Global medical device industry segment trend (2006-2011) (%)
Figure 3.6: Global medical device industry segment trend (2006-2011) US $B
Figure 3.7: Global medical device industry market opportunity by region (2011-2017) (%)
Figure 3.8: Global medical device industry market opportunity by segment (2011-2017) (%)
CHAPTER 4.COMPETITIVE BENCHMARKING (FINANCIAL AND MARKET)
Figure 4.1: Financial benchmarking of top 5 global medical device companies
Figure 4.2: Gross profit and net profit of top 5 players (2011)
Figure 4.3: Financial analysis - growth leadership quadrant (2011)
Figure 4.4: Global market share of top players in medical device industry (2006) (%)
Figure 4.5: Global market share of top players in medical device industry (2011) (%)
Figure 4.6: Market share analysis of top players in medical device industry (2006) (%)
Figure 4.7: Market share analysis of top players in medical device industry (2011) (E) (%)
Figure 4.8: Global market share analysis of top players in medical device industry (2011) (%)
Figure 4.9: Global medical device industry: 2011 market fragmentation/consolidation
Figure 4.10: Market value North America: US $B
Figure 4.11: Market value Europe: US $B
Figure 4.12: Market value Asia Pacific: US $B
Figure 4.13: Market value Row: US $B
Figure 4.14: Global medical device companies - 2011 regional revenue trend (US $B)
Figure 4.15: Global medical device companies - 2011 regional revenue trend (%)
Figure 4.16: North American revenue trend for top players 2007-2011 (US $B)
Figure 4.17: Europe revenue trend for top players 2007-2011 (US $B)
Figure 4.18: Asia Pacific revenue trend for top players 2007-2011 (US $B)
Figure 4.19: Row revenue trend for top players 2007-2011 (US $B)
Figure 4.20: Lucintel triad - top 5 major players
CHAPTER 5. COMPANY PROFILE OF JOHNSON & JOHNSON
Figure 5.1: Johnson & Johnson revenue by business structure 2011
Figure 5.2: Lucintel triad -Johnson & Johnson
Figure 5.3: Financial benchmarking of Johnson & Johnson against top 3 and top 5 industry players- average
Figure 5.4: Financial benchmarking of Johnson & Johnson against Top 5 best
Figure 5.5: Global industry revenue trend Vs Johnson & Johnson (2007-2011) in US $B
Figure 5.6: Global market share trend for Johnson & Johnson (2007-2011) in (%)
Figure 5.7: North American industry revenue trend Vs Johnson & Johnson 2007-2011 in US $B
Figure 5.8: European industry revenue trend Vs Johnson & Johnson 2007-2011 in US $B
Figure 5.9: APAC industry revenue trend Vs Johnson & Johnson 2007-2011 in US $B
Figure 5.10: ROW industry revenue trend Vs Johnson & Johnson 2007-2011 in US $B
Figure 5.11: North American market share trend for Johnson & Johnson 2007-2011 in (%)
Figure 5.12: European market share trend for Johnson & Johnson 2007-2011 in (%)
Figure 5.13: APAC market share trend for Johnson & Johnson 2007-2011 in (%)
Figure 5.14: ROW market share trend for Johnson & Johnson 2007-2011 in (%)
Figure 5.15: Trend in R&D expenses 2006-2011 in US $B
Figure 5.16: Trend in R&D expenses 2006-2011 in %
Figure 5.17: Comparison of for Johnson & Johnson 2007-2011 expenditure Vs top 3 & top 5 players average- 2011
Figure 5.18: Johnson & Johnson productivity: 2007-2011 in US$ M
Figure 5.19: Johnson & Johnson fixed asset value: 2007-2011 in US$ M
Figure 5.20: Strategic execution
CHAPTER 6. COMPANY PROFILE OF MEDTRONIC, INC.
Figure 6.1: Medtronic, Inc. revenue by business structure 2011
Figure 6.2: Lucintel triad -Medtronic, Inc.
Figure 6.3: Financial benchmarking of Medtronic, Inc. against top 3 and top 5 industry players- average
Figure 6.4: Financial benchmarking of Medtronic, Inc. against top 5 best
Figure 6.5: Global industry revenue trend Vs Medtronic, Inc. (2007-2011) in US $B
Figure 6.6: Global market share trend for Medtronic, Inc. (2007-2011) in (%)
Figure 6.7: North American industry revenue trend Vs Medtronic, Inc. 2007-2011 in US $B
Figure 6.8: European industry revenue trend Vs Medtronic, Inc. 2007-2011 in US $B
Figure 6.9: APAC industry revenue trend Vs Medtronic, Inc. 2007-2011 in US $B
Figure 6.10: ROW industry revenue trend Vs Medtronic, Inc. 2007-2011 in US $B
Figure 6.11: North American market share trend for Medtronic, Inc. 2007-2011 in (%)
Figure 6.12: European market share trend for Medtronic, Inc. 2007-2011 in (%)
Figure 6.13: APAC market share trend for Medtronic, Inc. 2007-2011 in (%)
Figure 6.14: ROW market share trend for Medtronic, Inc. 2007-2011 in (%)
Figure 6.15: Trend in R&D expenses 2006-2011 in US $B
Figure 6.16: Trend in R&D expenses 2006-2011 in %
Figure 6.17: Comparison of Medtronic, Inc. R&D expenditure VS top 3 & top 5 players- average-2011
Figure 6.18: Medtronic, Inc. productivity: 2007-2011 in US $M
Figure 6.19: Medtronic, Inc. fixed asset value: 2007-2011 in US $M
Figure 6.20: Strategic execution
CHAPTER 7. COMPANY PROFILE OF COVIDIEN PLC
Figure 7.1: Covidien Plcrevenue by business structure 2011
Figure 7.2: Lucintel triad - Covidien Plc
Figure 7.3: Financial benchmarking of Covidien Plc against top 3 and top 5 industry players- average
Figure 7.4: Financial benchmarking of Covidien Plcagainst Top 5 best
Figure 7.5: Global industry revenue trend VsCovidien Plc (2007-2011) in US $B
Figure 7.6: Global market share trend for Covidien Plc(2007-2011) in (%)
Figure 7.7: North American industry revenue trend Vs Covidien Plc (2007-2011) in US $B
Figure 7.8: European industry revenue trend Vs Covidien Plc (2007-2011) in US $B
Figure 7.9: APAC industry revenue trend Vs Covidien Plc (2007-2011) in US $B
Figure 7.10: ROW industry revenue trend Vs Covidien Plc (2007-2011) in US $B
Figure 7.11: North American market share trend for Covidien Plc (2007-2011) in (%)
Figure 7.12: European market share trend for Covidien Plc (2007-2011) in (%)
Figure 7.13: APAC market share trend for Covidien Plc (2007-2011) in (%)
Figure 7.14: ROW market share trend for Covidien Plc (2007-2011) in (%)
Figure 7.15: Trend in R&D expenses (2006-2011) in US $B
Figure 7.16: Trend in R&D expenses (2006-2011) in %
Figure 7.17: Covidien Plc R&D expenditure VS top 3 & top 5 players average- 2011
Figure 7.18: Covidien Plc Company productivity: 2007-2011 in US $M
Figure 7.19: Covidien Plc fixed asset value: 2007-2011 in US $M
Figure 7.20: Strategic execution
CHAPTER 8. COMPANY PROFILE OF BOSTON SCIENTIFIC CORPORATION
Figure 8.1: Boston Scientific revenue by business structure 2011
Figure 8.2: Lucintel triad - Boston Scientific
Figure 8.3: Financial benchmarking of Boston Scientific against top 3 and top 5 industry players- average
Figure 8.4: Financial benchmarking of Boston Scientific against Top 5 best
Figure 8.5: Global industry revenue trend Vs Boston Scientific(2007-2011) in US $B
Figure 8.6: Global market share trend for Boston Scientific(2007-2011) in (%)
Figure 8.7: North American industry revenue trend Vs Boston Scientific (2007-2011) in US $B
Figure 8.8: European industry revenue trend Vs Boston Scientific (2007-2011) in US $B
Figure 8.9: APAC industry revenue trend Vs Boston Scientific (2007-2011) in US $B
Figure 8.10: ROW industry revenue trend Vs Boston Scientific (2007-2011) in US $B
Figure 8.11: North American market share trend for Boston Scientific (2007- 2011) in (%)
Figure 8.12: European market share trend for Boston Scientific (2007- 2011) in (%)
Figure 8.13: APAC market share trend for Boston Scientific (2007- 2011) in (%)
Figure 8.14: ROW market share trend for Boston Scientific (2007- 2011) in (%)
Figure 8.15: Trend in R&D expenses (2006-2011) in US $B
Figure 8.16: Trend in R&D expenses (2006-2011) in %
Figure 8.17: Comparison of Boston Scientific R&D expenditure VS top 3 & top 5 players average- 2011
Figure 8.18Boston Scientific productivity: 2007-2011 in US $M
Figure 8.19: Boston Scientific fixed asset value: 2007-2011 in US $M
Figure 8.20: Strategic execution
CHAPTER 9. COMPANY PROFILE OF ABBOTT LABORATORIES
Figure 9.1: Abbott Laboratories revenue by business segments 2011
Figure 9.2: Lucintel triad- Abbott Laboratories
Figure 9.3: Financial benchmarking of Abbott Laboratories against top 3 and top 5 industry players- average
Figure 9.4: Financial benchmarking of Abbott Laboratories against Top 5 best
Figure 9.5: Global industry revenue trend Vs: Abbott Laboratories(2007-2011) in US $B
Figure 9.6: Global market share trend for Abbott Laboratories (2007-2011) in (%)
Figure 9.7: North American industry revenue trend Vs Abbott Laboratories (2007-2011) in US $B
Figure 9.8: European industry revenue trend Vs Abbott Laboratories (2007-2011) in US $B
Figure 9.9: APAC industry revenue trend Vs Abbott Laboratories (2007-2011) in US $B
Figure 9.10: ROW industry revenue trend Vs Abbott Laboratories (2007-2011) in US $B
Figure 9.11: North American market share trend for Abbott Laboratories(2007-2011) in (%)
Figure 9.12: European market share trend for Abbott Laboratories (2007-2011) in (%)
Figure 9.13: APAC market share trend for Abbott Laboratories (2007-2011) in (%)
Figure 9.14: ROW market share trend for Abbott Laboratories (2007-2011) in (%)
Figure 9.15: Trend in R&D expenses (2006-2011) in US $B
Figure 9.16: Trend in R&D expenses (2006-2011) in %
Figure 9.17: Comparison of Abbott Laboratories R&D expenditure VS top 3 & top 5 players average- 2011
Figure 9.18: Abbott Laboratories productivity: 2007-2011 in US $M
Figure 9.19: Abbott Laboratories fixed asset value: 2007-2011 in US $M
Figure 9.20: Strategic execution
CHAPTER 3. MARKET OPPORTUNITY
Figure 3.1: Supply chain for medical device industry
Figure 3.2: Global medical device industry trend (2006-2011)
Figure 3.3: Global medical device industry regional trend (2006-2011) US $B
Figure 3.4: Global medical device industry regional trend (2006-2011) (%)
Figure 3.5: Global medical device industry segment trend (2006-2011) (%)
Figure 3.6: Global medical device industry segment trend (2006-2011) US $B
Figure 3.7: Global medical device industry market opportunity by region (2011-2017) (%)
Figure 3.8: Global medical device industry market opportunity by segment (2011-2017) (%)
CHAPTER 4.COMPETITIVE BENCHMARKING (FINANCIAL AND MARKET)
Figure 4.1: Financial benchmarking of top 5 global medical device companies
Figure 4.2: Gross profit and net profit of top 5 players (2011)
Figure 4.3: Financial analysis - growth leadership quadrant (2011)
Figure 4.4: Global market share of top players in medical device industry (2006) (%)
Figure 4.5: Global market share of top players in medical device industry (2011) (%)
Figure 4.6: Market share analysis of top players in medical device industry (2006) (%)
Figure 4.7: Market share analysis of top players in medical device industry (2011) (E) (%)
Figure 4.8: Global market share analysis of top players in medical device industry (2011) (%)
Figure 4.9: Global medical device industry: 2011 market fragmentation/consolidation
Figure 4.10: Market value North America: US $B
Figure 4.11: Market value Europe: US $B
Figure 4.12: Market value Asia Pacific: US $B
Figure 4.13: Market value Row: US $B
Figure 4.14: Global medical device companies - 2011 regional revenue trend (US $B)
Figure 4.15: Global medical device companies - 2011 regional revenue trend (%)
Figure 4.16: North American revenue trend for top players 2007-2011 (US $B)
Figure 4.17: Europe revenue trend for top players 2007-2011 (US $B)
Figure 4.18: Asia Pacific revenue trend for top players 2007-2011 (US $B)
Figure 4.19: Row revenue trend for top players 2007-2011 (US $B)
Figure 4.20: Lucintel triad - top 5 major players
CHAPTER 5. COMPANY PROFILE OF JOHNSON & JOHNSON
Figure 5.1: Johnson & Johnson revenue by business structure 2011
Figure 5.2: Lucintel triad -Johnson & Johnson
Figure 5.3: Financial benchmarking of Johnson & Johnson against top 3 and top 5 industry players- average
Figure 5.4: Financial benchmarking of Johnson & Johnson against Top 5 best
Figure 5.5: Global industry revenue trend Vs Johnson & Johnson (2007-2011) in US $B
Figure 5.6: Global market share trend for Johnson & Johnson (2007-2011) in (%)
Figure 5.7: North American industry revenue trend Vs Johnson & Johnson 2007-2011 in US $B
Figure 5.8: European industry revenue trend Vs Johnson & Johnson 2007-2011 in US $B
Figure 5.9: APAC industry revenue trend Vs Johnson & Johnson 2007-2011 in US $B
Figure 5.10: ROW industry revenue trend Vs Johnson & Johnson 2007-2011 in US $B
Figure 5.11: North American market share trend for Johnson & Johnson 2007-2011 in (%)
Figure 5.12: European market share trend for Johnson & Johnson 2007-2011 in (%)
Figure 5.13: APAC market share trend for Johnson & Johnson 2007-2011 in (%)
Figure 5.14: ROW market share trend for Johnson & Johnson 2007-2011 in (%)
Figure 5.15: Trend in R&D expenses 2006-2011 in US $B
Figure 5.16: Trend in R&D expenses 2006-2011 in %
Figure 5.17: Comparison of for Johnson & Johnson 2007-2011 expenditure Vs top 3 & top 5 players average- 2011
Figure 5.18: Johnson & Johnson productivity: 2007-2011 in US$ M
Figure 5.19: Johnson & Johnson fixed asset value: 2007-2011 in US$ M
Figure 5.20: Strategic execution
CHAPTER 6. COMPANY PROFILE OF MEDTRONIC, INC.
Figure 6.1: Medtronic, Inc. revenue by business structure 2011
Figure 6.2: Lucintel triad -Medtronic, Inc.
Figure 6.3: Financial benchmarking of Medtronic, Inc. against top 3 and top 5 industry players- average
Figure 6.4: Financial benchmarking of Medtronic, Inc. against top 5 best
Figure 6.5: Global industry revenue trend Vs Medtronic, Inc. (2007-2011) in US $B
Figure 6.6: Global market share trend for Medtronic, Inc. (2007-2011) in (%)
Figure 6.7: North American industry revenue trend Vs Medtronic, Inc. 2007-2011 in US $B
Figure 6.8: European industry revenue trend Vs Medtronic, Inc. 2007-2011 in US $B
Figure 6.9: APAC industry revenue trend Vs Medtronic, Inc. 2007-2011 in US $B
Figure 6.10: ROW industry revenue trend Vs Medtronic, Inc. 2007-2011 in US $B
Figure 6.11: North American market share trend for Medtronic, Inc. 2007-2011 in (%)
Figure 6.12: European market share trend for Medtronic, Inc. 2007-2011 in (%)
Figure 6.13: APAC market share trend for Medtronic, Inc. 2007-2011 in (%)
Figure 6.14: ROW market share trend for Medtronic, Inc. 2007-2011 in (%)
Figure 6.15: Trend in R&D expenses 2006-2011 in US $B
Figure 6.16: Trend in R&D expenses 2006-2011 in %
Figure 6.17: Comparison of Medtronic, Inc. R&D expenditure VS top 3 & top 5 players- average-2011
Figure 6.18: Medtronic, Inc. productivity: 2007-2011 in US $M
Figure 6.19: Medtronic, Inc. fixed asset value: 2007-2011 in US $M
Figure 6.20: Strategic execution
CHAPTER 7. COMPANY PROFILE OF COVIDIEN PLC
Figure 7.1: Covidien Plcrevenue by business structure 2011
Figure 7.2: Lucintel triad - Covidien Plc
Figure 7.3: Financial benchmarking of Covidien Plc against top 3 and top 5 industry players- average
Figure 7.4: Financial benchmarking of Covidien Plcagainst Top 5 best
Figure 7.5: Global industry revenue trend VsCovidien Plc (2007-2011) in US $B
Figure 7.6: Global market share trend for Covidien Plc(2007-2011) in (%)
Figure 7.7: North American industry revenue trend Vs Covidien Plc (2007-2011) in US $B
Figure 7.8: European industry revenue trend Vs Covidien Plc (2007-2011) in US $B
Figure 7.9: APAC industry revenue trend Vs Covidien Plc (2007-2011) in US $B
Figure 7.10: ROW industry revenue trend Vs Covidien Plc (2007-2011) in US $B
Figure 7.11: North American market share trend for Covidien Plc (2007-2011) in (%)
Figure 7.12: European market share trend for Covidien Plc (2007-2011) in (%)
Figure 7.13: APAC market share trend for Covidien Plc (2007-2011) in (%)
Figure 7.14: ROW market share trend for Covidien Plc (2007-2011) in (%)
Figure 7.15: Trend in R&D expenses (2006-2011) in US $B
Figure 7.16: Trend in R&D expenses (2006-2011) in %
Figure 7.17: Covidien Plc R&D expenditure VS top 3 & top 5 players average- 2011
Figure 7.18: Covidien Plc Company productivity: 2007-2011 in US $M
Figure 7.19: Covidien Plc fixed asset value: 2007-2011 in US $M
Figure 7.20: Strategic execution
CHAPTER 8. COMPANY PROFILE OF BOSTON SCIENTIFIC CORPORATION
Figure 8.1: Boston Scientific revenue by business structure 2011
Figure 8.2: Lucintel triad - Boston Scientific
Figure 8.3: Financial benchmarking of Boston Scientific against top 3 and top 5 industry players- average
Figure 8.4: Financial benchmarking of Boston Scientific against Top 5 best
Figure 8.5: Global industry revenue trend Vs Boston Scientific(2007-2011) in US $B
Figure 8.6: Global market share trend for Boston Scientific(2007-2011) in (%)
Figure 8.7: North American industry revenue trend Vs Boston Scientific (2007-2011) in US $B
Figure 8.8: European industry revenue trend Vs Boston Scientific (2007-2011) in US $B
Figure 8.9: APAC industry revenue trend Vs Boston Scientific (2007-2011) in US $B
Figure 8.10: ROW industry revenue trend Vs Boston Scientific (2007-2011) in US $B
Figure 8.11: North American market share trend for Boston Scientific (2007- 2011) in (%)
Figure 8.12: European market share trend for Boston Scientific (2007- 2011) in (%)
Figure 8.13: APAC market share trend for Boston Scientific (2007- 2011) in (%)
Figure 8.14: ROW market share trend for Boston Scientific (2007- 2011) in (%)
Figure 8.15: Trend in R&D expenses (2006-2011) in US $B
Figure 8.16: Trend in R&D expenses (2006-2011) in %
Figure 8.17: Comparison of Boston Scientific R&D expenditure VS top 3 & top 5 players average- 2011
Figure 8.18Boston Scientific productivity: 2007-2011 in US $M
Figure 8.19: Boston Scientific fixed asset value: 2007-2011 in US $M
Figure 8.20: Strategic execution
CHAPTER 9. COMPANY PROFILE OF ABBOTT LABORATORIES
Figure 9.1: Abbott Laboratories revenue by business segments 2011
Figure 9.2: Lucintel triad- Abbott Laboratories
Figure 9.3: Financial benchmarking of Abbott Laboratories against top 3 and top 5 industry players- average
Figure 9.4: Financial benchmarking of Abbott Laboratories against Top 5 best
Figure 9.5: Global industry revenue trend Vs: Abbott Laboratories(2007-2011) in US $B
Figure 9.6: Global market share trend for Abbott Laboratories (2007-2011) in (%)
Figure 9.7: North American industry revenue trend Vs Abbott Laboratories (2007-2011) in US $B
Figure 9.8: European industry revenue trend Vs Abbott Laboratories (2007-2011) in US $B
Figure 9.9: APAC industry revenue trend Vs Abbott Laboratories (2007-2011) in US $B
Figure 9.10: ROW industry revenue trend Vs Abbott Laboratories (2007-2011) in US $B
Figure 9.11: North American market share trend for Abbott Laboratories(2007-2011) in (%)
Figure 9.12: European market share trend for Abbott Laboratories (2007-2011) in (%)
Figure 9.13: APAC market share trend for Abbott Laboratories (2007-2011) in (%)
Figure 9.14: ROW market share trend for Abbott Laboratories (2007-2011) in (%)
Figure 9.15: Trend in R&D expenses (2006-2011) in US $B
Figure 9.16: Trend in R&D expenses (2006-2011) in %
Figure 9.17: Comparison of Abbott Laboratories R&D expenditure VS top 3 & top 5 players average- 2011
Figure 9.18: Abbott Laboratories productivity: 2007-2011 in US $M
Figure 9.19: Abbott Laboratories fixed asset value: 2007-2011 in US $M
Figure 9.20: Strategic execution
LIST OF TABLES
CHAPTER 3. MARKET OPPORTUNITY
Table 3.1: Global medical device industry parameters 2011
Table 3.2: Relative market attractiveness by region
Table 3.3: Growth rate by region (2006-2011)
Table 3.4: Growth rate by region (2006-2011)
CHAPTER 4. COMPETITIVE BENCHMARKING (FINANCIAL AND MARKET)
Table 4.1: Financial benchmarking of Top 5global medical device companies
Table 4.2: Key financial parameters for Top 5 Global Medical Device
Table 4.3: Regional revenue (in $B)
Table 4.4: Regional revenue (in %)
Table 4.5: Competitors based on markets served
Table 4.6: Lucintel triad - Top 5 major players
CHAPTER 5. COMPANY PROFILE OF JOHNSON & JOHNSON
Table 5.1: Market served: Johnson & Johnson
Table 5.2: Lucintel triad - Johnson & Johnson
Table 5.3: Financial benchmarking of Johnson & Johnson against best and against Top 3 and top 5 industry players- average
Table 5.4: Strategic execution - product positioning by segment
Table 5.5: Strategic execution - perceived customer value / quality
Table 5.6: Strategic execution - promotion / communications
Table 5.7: Strategic execution - product distribution by region
CHAPTER 6. COMPANY PROFILE OF MEDTRONIC, INC.
Table 6.1: Market served -Medtronic, Inc.
Table 6.2: Lucintel triad - Medtronic, Inc.
Table 6.3: Financial benchmarking of Medtronic, Inc. against best and against Top 3 and top 5 industry players- average
Table 6.4: Strategic execution - product positioning by segment
Table 6.5: Strategic execution - perceived customer value / quality
Table 6.6: Strategic execution - promotion / communications
Table 6.7: Strategic execution - product distribution by region
CHAPTER 7. COMPANY PROFILE OF COVIDIEN PLC
Table 7.1: Market served -Covidien Plc
Table 7.2: Lucintel triad - Covidien Plc
Table 7.3: Financial benchmarking of Covidien Plcagainst best and against Top 3 and top 5 industry players- average
Table 7.4: Strategic execution - product positioning by segment
Table 7.5: Strategic execution - perceived customer value / quality
Table 7.6: Strategic execution - promotion / communications
Table 7.7: Strategic execution - product distribution by region
CHAPTER 8. COMPANY PROFILE OF BOSTON SCIENTIFIC CORPORATION
Table 8.1: Market served-Boston Scientific
Table 8.2: Lucintel triad - Boston Scientific
Table 8.3: Financial benchmarking of Boston Scientific against best and against Top 3 and top 5 industry players- average
Table 8.4: Strategic execution - product positioning by segment
Table 8.5: Strategic execution - perceived customer value / quality
Table 8.6: Strategic execution - promotion / communications
Table 8.7: Strategic execution - product distribution by region
CHAPTER 9. COMPANY PROFILE OF ABBOTT LABORATORIES
Table 9.1: Markets served -Abbott Laboratories
Table 9.2: Lucintel triad - Abbott Laboratories
Table 9.3: Financial benchmarking of Abbott Laboratories against best and against Top 3 and top 5 industry players- average
Table 9.4: Strategic execution - product positioning by segment
Table 9.5: Strategic execution - perceived customer value / quality
Table 9.6: Strategic execution - promotion / communications
Table 9.7: Strategic execution - product distribution by region
CHAPTER 3. MARKET OPPORTUNITY
Table 3.1: Global medical device industry parameters 2011
Table 3.2: Relative market attractiveness by region
Table 3.3: Growth rate by region (2006-2011)
Table 3.4: Growth rate by region (2006-2011)
CHAPTER 4. COMPETITIVE BENCHMARKING (FINANCIAL AND MARKET)
Table 4.1: Financial benchmarking of Top 5global medical device companies
Table 4.2: Key financial parameters for Top 5 Global Medical Device
Table 4.3: Regional revenue (in $B)
Table 4.4: Regional revenue (in %)
Table 4.5: Competitors based on markets served
Table 4.6: Lucintel triad - Top 5 major players
CHAPTER 5. COMPANY PROFILE OF JOHNSON & JOHNSON
Table 5.1: Market served: Johnson & Johnson
Table 5.2: Lucintel triad - Johnson & Johnson
Table 5.3: Financial benchmarking of Johnson & Johnson against best and against Top 3 and top 5 industry players- average
Table 5.4: Strategic execution - product positioning by segment
Table 5.5: Strategic execution - perceived customer value / quality
Table 5.6: Strategic execution - promotion / communications
Table 5.7: Strategic execution - product distribution by region
CHAPTER 6. COMPANY PROFILE OF MEDTRONIC, INC.
Table 6.1: Market served -Medtronic, Inc.
Table 6.2: Lucintel triad - Medtronic, Inc.
Table 6.3: Financial benchmarking of Medtronic, Inc. against best and against Top 3 and top 5 industry players- average
Table 6.4: Strategic execution - product positioning by segment
Table 6.5: Strategic execution - perceived customer value / quality
Table 6.6: Strategic execution - promotion / communications
Table 6.7: Strategic execution - product distribution by region
CHAPTER 7. COMPANY PROFILE OF COVIDIEN PLC
Table 7.1: Market served -Covidien Plc
Table 7.2: Lucintel triad - Covidien Plc
Table 7.3: Financial benchmarking of Covidien Plcagainst best and against Top 3 and top 5 industry players- average
Table 7.4: Strategic execution - product positioning by segment
Table 7.5: Strategic execution - perceived customer value / quality
Table 7.6: Strategic execution - promotion / communications
Table 7.7: Strategic execution - product distribution by region
CHAPTER 8. COMPANY PROFILE OF BOSTON SCIENTIFIC CORPORATION
Table 8.1: Market served-Boston Scientific
Table 8.2: Lucintel triad - Boston Scientific
Table 8.3: Financial benchmarking of Boston Scientific against best and against Top 3 and top 5 industry players- average
Table 8.4: Strategic execution - product positioning by segment
Table 8.5: Strategic execution - perceived customer value / quality
Table 8.6: Strategic execution - promotion / communications
Table 8.7: Strategic execution - product distribution by region
CHAPTER 9. COMPANY PROFILE OF ABBOTT LABORATORIES
Table 9.1: Markets served -Abbott Laboratories
Table 9.2: Lucintel triad - Abbott Laboratories
Table 9.3: Financial benchmarking of Abbott Laboratories against best and against Top 3 and top 5 industry players- average
Table 9.4: Strategic execution - product positioning by segment
Table 9.5: Strategic execution - perceived customer value / quality
Table 9.6: Strategic execution - promotion / communications
Table 9.7: Strategic execution - product distribution by region
